Kezar Life Sciences (KZR) Total Debt (2021 - 2025)
Kezar Life Sciences (KZR) has disclosed Total Debt for 5 consecutive years, with $6.7 million as the latest value for Q3 2025.
- Quarterly Total Debt fell 35.17% to $6.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Sep 2025, down 35.17% year-over-year, with the annual reading at $10.3 million for FY2024, 2.57% up from the prior year.
- Total Debt hit $6.7 million in Q3 2025 for Kezar Life Sciences, down from $7.9 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $10.3 million in Q4 2024 to a low of $6.7 million in Q3 2025.
- Historically, Total Debt has averaged $9.6 million across 5 years, with a median of $9.9 million in 2022.
- Biggest five-year swings in Total Debt: increased 2.57% in 2024 and later crashed 35.17% in 2025.
- Year by year, Total Debt stood at $9.6 million in 2021, then rose by 2.2% to $9.8 million in 2022, then rose by 2.39% to $10.1 million in 2023, then rose by 2.57% to $10.3 million in 2024, then tumbled by 35.58% to $6.7 million in 2025.
- Business Quant data shows Total Debt for KZR at $6.7 million in Q3 2025, $7.9 million in Q2 2025, and $9.1 million in Q1 2025.